Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 11, 2023
[177Lu]Lu-PSMA-Radioligand Therapy Efficacy Outcomes in Taxane-Naïve Versus Taxane-Treated Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and MetaanalysisSwayamjeet Satapathy, Ranjit K Sahoo, Chandrasekhar Bal
Clinical Nuclear Medicine|September 6, 2017
Concomitant 177Lu-DOTATATE and Capecitabine Therapy in Patients With Advanced Neuroendocrine Tumors: A Long-term-Outcome, Toxicity, Survival, and Quality-of-Life StudySanjana Ballal, Madhav P Yadav, Nishikant A Damle, et al.
BMC Infectious Diseases|July 18, 2026
Temporary Glucose - 6 phosphate dehydrogenase enzyme deficiency, an additional risk factor for invasive fungal infection in immune-compromised AML patientsSampa Ghose, Christine Wilson, Preity Sharma, et al.
The Prostate|April 27, 2021
225 Ac-PSMA-617-targeted alpha therapy for the treatment of metastatic castration-resistant prostate cancer: A systematic review and meta-analysisSanjana Ballal, Madhav P Yadav, Ranjit K Sahoo, et al.
Nuclear Medicine Communications|October 27, 2016
Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancerMadhav P Yadav, Sanjana Ballal, Madhavi Tripathi, et al.
Cureus|January 22, 2024
Clinico-Hematological Profile of Acute Myeloid Leukemia: Experience From a Tertiary Care Cancer Center in North IndiaArushi Vemprala, Smeeta Gajendra, Ritu Gupta, et al.
American Journal of Clinical Pathology|January 13, 2025
Comparative evaluation of PD-L1 expression and tumor immune microenvironment in molecular subtypes of muscle-invasive bladder cancer and its correlation with survival outcomesHena Khandakar, Seema Kaushal, Amlesh Seth, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2023
Long-term survival outcomes of salvage [225Ac]Ac-PSMA-617 targeted alpha therapy in patients with PSMA-expressing end-stage metastatic castration-resistant prostate cancer: a real-world studySanjana Ballal, Madhav P Yadav, Swayamjeet Satapathy, et al.
Pathology, Research and Practice|November 16, 2019
SPARC expression in desmoplastic and non desmoplastic pancreatic carcinoma and cholangiocarcinomaKhusbu Khetan, Vandana Baloda, Ranjit K Sahoo, et al.
Indian Journal of Pathology & Microbiology|June 17, 2021
Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinomaKhushbu Khetan, Ranjit K Sahoo, Vandana Baloda, et al.
Pageof 2